Multisubstituted Imidazole Synthesis via Ionic Liquid Catalyst
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for new therapeutically active agents for treating various diseases and conditions, including microbial infections, which are difficult to synthesize efficiently without solvents and with high yields, using easily recyclable catalysts and minimizing reaction times.
Innovation Solution
A multisubstituted imidazole compound, 2-(Benzo[b]thiophen-3-yl)-1-butyl-4,5-diphenyl-1H-imidazole, is synthesized via a four-component cyclocondensation reaction using an ionic liquid catalyst, piperidinium hydrogen sulfate, without solvents, achieving high yields and ease of use, with the product showing antimicrobial and anti-inflammatory activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional synthesis methods are used for imidazole compounds, then the compounds can be obtained, but the synthesis is difficult and yields are low
Solution Approach 1:
The patent changes the reaction parameters by using ionic liquid catalysts instead of conventional catalysts, performing reactions without solvents, and optimizing temperature and time parameters to achieve high yields (80-95%) and simplify the synthesis process
Solution Approach 2:
The patent introduces ionic liquids as intermediary catalysts that facilitate the cyclocondensation reaction between aldehydes, ketones, and amines to form imidazole compounds, enabling efficient synthesis with high yields and easy purification
2Productivity
If conventional catalysts are used, then the reaction can proceed, but the catalyst cannot be easily recycled
Solution Approach 1:
The patent implements catalyst recovery by filtering the reaction mixture to separate and reuse the ionic liquid catalyst, while discarding consumable materials, thereby maintaining high reaction efficiency across multiple cycles and reducing waste
Solution Approach 2:
The ionic liquid catalysts are designed to be inherently recoverable through simple filtration and can be reused multiple times without significant loss of activity, making the system self-sustaining and reducing the need for continuous catalyst replenishment
3Productivity
If solvents are used in the synthesis, then the reaction can proceed, but the method is not pure and requires additional purification steps
Solution Approach 1:
The patent removes solvents from the reaction system entirely, performing solvent-free cyclocondensation reactions that produce clean products requiring minimal purification, thereby eliminating solvent-related contamination and simplifying the overall process
4Productivity
If reaction time is extended to improve yield, then more product is obtained, but the process becomes less efficient
Solution Approach 1:
The patent uses ionic liquid catalysts that enable reactions to proceed rapidly within specific time frames (1-4 hours), creating an optimized periodic process that achieves high yields without excessive time investment, balancing productivity and efficiency
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method produces the compound with exceptional yields (about 95%) and allows for efficient antimicrobial and anti-inflammatory activity, with the ionic liquid catalyst being recyclable and reaction components purifiable by non-chromatographic techniques, demonstrating high therapeutic effectiveness.
Implementation Method 1
The reaction can employ an ionic liquid catalyst, piperidinium hydrogen sulfate (PHS)
Implementation Method 2
using a four-component cyclocondensation reaction between diphenylethanedione, aliphatic amines (n-butylamine) and 1-benzothiophene-3-carbaldehyde together with CH3COONH4
Implementation Method 3
heating the reaction mixture with stirring until reaction completion
Data Source
AI summary
A compound 2-(Benzo[b]thiophen-3-yl)-1-butyl-4,5-diphenyl-1H-imidazole compound, its synthesis, and its use as an anti-microbial and anti-inflammatory agent.